|

Most often prescribed for recurrent brain tumors, the GliaSite Radiation Therapy System (RTS) is designed to deliver site-specific internal radiation therapy and minimize radiation exposure to healthy brain tissue.
The GliaSite delivers radiation utilizing a liquid radioactive source placed inside a balloon catheter. Targeted tissue receives a high dose of radiation, while exposure to healthy tissue is minimized. Treatment is administered for 3 to 7 days.
For more information please visit www.proximatherapeutics.com
|